LLNI Funded Publications
We are incredibly proud of every publication that LLNI funding has contributed to.
Publishing and sharing this information and data is integral to finding answers for the future.
The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms.
Author:Greenfield G
Other Authors: McPherson S, Mills K, McMullin MF,
Last Updated:25/07/2019
Source:PubMed
Original Source:PubMed
Type:Journal Article
DOI:10.1186/s12967-018-1729-7
Journal:Journal of translational medicine
Volume:16
Issue:1
Pages:360
Date: December 2018
Link:https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1729-7
